Pilotstudie zur Evaluierung eines Impfstoffes mit Salmonella typhi Ty21a als Träger für rekombinante Urease von Helicobacter pylori
Helicobacter pylori urease was expressed in the common live typhoid vaccine Salmonella typhi Ty21a (Typhoral() yielding Salmonella typhi Ty21a(pDB1). Nine volunteers received Salmonella typhi Ty21a(pDB1) and three control volunteers received Salmonella typhi Ty21a. No serious adverse effects were observed in any of the volunteers. Ten out of 12 volunteers developed humoral immune responses to the Salmonella carrier as detected by antigen-specific antibody-secreting cells but only two volunteers seroconverted. A total of five volunteers showed cellular responses to the carrier. Six out of nine volunteers that had received Salmonella typhi Ty21a(pDB1) showed a T-cell response to Helicobacter urease in at least one of the three assays for detection of cellular response (Proliferation, T-cell-Elispot, IFN-gamma Elisa). No volunteer had detectable humoral responses to urease. Salmonella typhi Ty21a(pDB1) is a suitable prototype to optimize Salmonella-based vaccination for efficient cellular responses that could mediate protective immunity against Helicobacter.
School:Humboldt-Universität zu Berlin
Source Type:Master's Thesis
Keywords:Helicobacter pylori Salmonella typhi Vaccine Cellular immune responses
Date of Publication:07/19/2004